BackReneo Pharmaceuticals Overview

Reneo Pharmaceuticals Total Assets

Latest total assets for RPHM: $170M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$167.08M
↑ 129.39% YoYΔ $94.24M vs prior year quarter

Peer trimmed avg / median

Loading

Reneo Pharmaceuticals Total Assets History

Loading

Reneo Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Reneo Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Reneo Pharmaceuticals (RPHM) FAQ

Reneo Pharmaceuticals (RPHM) currently reports a total assets of $170M as of September 2026. That compares with $73M in the prior-year period — up 129.4% year over year. Use the charts on this page to explore Reneo Pharmaceuticals's total assets history and peer comparisons.

Reneo Pharmaceuticals's total assets increased from $73M to $170M — a 129.4% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reneo Pharmaceuticals reported $170M in total assets as of September 2026. That compares with $73M in the prior-year period — up 129.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reneo Pharmaceuticals, and consider following RPHM for alerts when major investors trade the stock.

Reneo Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPHM with unrelated industries.